Impact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer
Recruiting
N/A
Interventional Study
Head and Neck Cancers
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 66 (estimated)
- Sponsor
- Federal University of Minas Gerais · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cancer patients undergoing surgery are at high risk of malnutrition due to the effects of the tumor and surgical stress, which can lead to worse clinical outcomes. This study aims to evaluate the impact of beta-hydroxy-beta-methylbutyrate (HMB) supplementation on inflammatory markers and clinical outcomes in patients with malignant tumors of the upper airways and digestive tract undergoing surgery…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals aged 18 years or older;
* Both sexes (male and female);
* Patients treated at the outpatient clinic for head and neck carcinoma;
* Indication for potentially curative tumor resection surgery.
Exclusion Criteria:
* Diagnosis of cancer of the face, skin, paranasal …
Contacts